bpc-157 synthetic gastric pentadecapeptide — 50mg | Tissue Repair BPC 157 | Gastric Pentadecapeptide

MOTs-c is a unique peptide encoded by the mitochondrial genome rather than the nuclear DNA

Patients may reach a maintenance dose with this medication generally after several weeks to months, depending on their response and the presence of any side effects

Moreover, increased pressure has been shown to enhance cancer cell migration and resistance to the anticancer drug doxorubicin by upregulating the water channel aquaporin 1 [52] and the efflux transporter ABCC1 [53], respectively

Cycle Most community protocols run 612 weeks total, often loading + maintenance

This scientific identification does not establish safety, efficacy or suitability for any medical, diagnostic, consumer or veterinary application

It's long enough to reliably reach the subcutaneous layer without being intimidating or going too deep